semaglutide pulled from market Despite FDA ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the Semaglutide Market Size & Share,

HCRU was assessed over the baseline and follow-up periods (including index date) and expressed as both the proportion of patients with utilization, and as per-patient number of visits averaged across both cohorts

Ideal candidates include those with a BMI of 30 or greater, or those at a BMI of 27 or above with conditions such as hypertension or high cholesterol

Increasing too quickly means youre piling dose increases on top of each other before reaching steady state at any of them, making it impossible to know which dose is producing which effects

Common side effects include nausea, diarrhea, vomiting, and constipation

Drucker DJ, Nauck MA